FDA Adverse Event Malfunction Summary report: N

RAYONE GALAXY

MDR report key: 22105082 · Received May 29, 2025

Report

Report Number
3012304651-2025-00149
Event Type
Malfunction
Date Received
May 29, 2025
Date of Event
March 11, 2025
Report Date
May 29, 2025
Manufacturer
RAYNER INTRAOCULAR LENSES LIMITED
Product Code
HQL
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE REFERENCE (B)(4) HAS BEEN ALLOCATED TO THIS CASE BY RAYNER. THE EVENT DESCRIPTION PROVIDED STATES THAT POST-OPERATIVELY THE PATIENT PRESENTED WITH PCO. IOL IMPLANTATION WAS PERFORMED ON (B)(6) 2024 AND PCO WAS FIRST OBSERVED ON (B)(6) 2025. THE PATIENT UNDERWENT AN ADDITIONAL SURGERY TO HAVE A ND:YAG CAPSULOTOMY PERFORMED. THE DEVICE IS NOT AVAILABLE FOR RETURN, THE IOL REMAINS IMPLANTED. PCO IS OFTEN REFERRED TO AS "SECONDARY CATARACT" AND IS DUE TO THE MIGRATION, PROLIFERATION AND DIFFERENTIATION OF LENS EPITHELIAL CELLS. ACCORDING TO THE AMERICAN ACADEMY OF OPHTHALMOLOGY, PCO OCCURS IN 20-50% OF PATIENTS WITHIN 2-5 YEARS OF UNDERGOING CATARACT SURGERY. POTENTIAL RISK FACTORS INCLUDE THE PRESENCE OF CONDITIONS SUCH AS DIABETES, UVEITIS, MYOTONIC DYSTROPHY, RETINITIS PIGMENTOSA AND TRAUMATIC CATARACT. THE PATIENT IN THIS CASE PRESENTED WITH PCO THREE MONTHS AFTER CATARACT SURGERY. THIS IS TOO SOON FOR TYPICAL PCO AND THIS MAY INDICATE THAT SOME OTHER CONDITION CAUSED THE ONSET OF SYMPTOMS E.G., FIBRIN REACTION. CAPSULAR BAG DISTENSION SYNDROME (CBDS); HOWEVER, THIS CANNOT BE VERIFIED. OUR REVIEW OF PRODUCTION RECORDS FOR THE RAYONE GALAXY RAO605G BATCH 064244168 SHOWED THAT ALL MANUFACTURING AND QUALITY CHECKS WERE CONDUCTED WITH SUCCESSFUL RESULTS. ALL DEVICES RELEASED FOR DISTRIBUTION FROM THIS BATCH WERE WITHIN TOLERANCE, MET SPECIFICATION CRITERIA AND WERE WITHOUT DEFECTS. THE ROOT CAUSE CANNOT BE ESTABLISHED FROM THE LIMITED EVIDENCE AND INFORMATION AVAILABLE.

Description of Event or Problem · 0

ON 13TH MAY 2025, RAYNER RECEIVED NOTIFICATION FROM A US HEALTHCARE PROFESSIONAL OF AN EVENT THAT OCCURRED FOLLOWING IMPLANTATION OF A RAYONE GALAXY RAO605G. THE EVENT DESCRIPTION PROVIDED STATES THAT POST-OPERATIVELY THE PATIENT PRESENTED WITH POSTERIOR CAPSULE OPACIFICATION (PCO) WHICH NECESSITATED AN ADDITIONAL SURGERY TO YAG THE LENS. NOTE: RAYONE GALAXY STUDY SUBJECT: (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
994185 RAYONE GALAXY RAYONE GALAXY HQL RAYNER INTRAOCULAR LENSES LIMITED RAO605G 064244168

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown